Efficacy and safety of eribulin in the treatment of advanced adult soft tissue sarcoma (STS): First real-world data in Chinese population.

被引:0
|
作者
Guo, Xi [1 ]
Zhou, Yuhong [1 ]
Zhuang, Rongyuan [1 ]
You, Yang [1 ]
Zhang, Chenlu [1 ]
Wang, Zhiming [1 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Dept Med Oncol, Shanghai, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
11577
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Pazopanib treatment outcome in advanced soft tissue sarcoma: Real-world data
    Alshamsan, B.
    Alshibany, A.
    Badran, A.
    Maraiki, F.
    Elshenawy, M. A.
    Elhassan, T.
    Atallah, J. P.
    ANNALS OF ONCOLOGY, 2020, 31 : S987 - S987
  • [2] Adult Soft Tissue Sarcoma: A Prospective Observational Real-World Data
    Shivarudraiah, Shivashankara Mathighatta
    Viswanath, Sundaram
    Pandalanghat, Suresh
    Soneji, Dharmesh
    Kumar, Manish
    Patel, Amol
    Guleria, Bupesh
    Pathi, Nikhil
    Sud, Rahul
    Pathak, Abhishek
    Rathore, Anvesh
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2021, 42 (04) : 339 - 345
  • [3] Real-world efficacy, safety data and predictive clinical parameters for treatment outcomes in advanced soft tissue sarcoma treated with combined immunotherapy and antiangiogenic therapy
    Li, Shaoli
    Sun, Qunan
    Bai, Rui
    Wang, Youping
    Wang, Hui
    Chen, Haifeng
    Dong, Ying
    BMC CANCER, 2024, 24 (01)
  • [4] Safety and efficacy of eribulin mesylate in patients with advanced soft tissue sarcoma in daily practice
    Inagaki, C.
    Shimoi, T.
    Okuma, H. S.
    Kawachi, A.
    Shimomura, A.
    Noguchi, E.
    Yunokawa, M.
    Yonemori, K.
    Shimizu, C.
    Fujiwara, Y.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [5] Efficacy of eribulin administered in combination with an immune checkpoint inhibitor (ICI) and anlotinib as salvage treatment for patients (pts) with advanced adult soft tissue sarcoma (STS)
    Guo, Xi
    Zhou, Yuhong
    Zhuang, Rongyuan
    Zhang, Chenlu
    You, Yang
    Li, Wei
    Wang, Zhiming
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Real-world evidence of the efficacy and tolerability of trabectedin in patients with advanced soft-tissue sarcoma
    de Sande Gonzalez, Luis Miguel
    Martin-Broto, Javier
    Kasper, Bernd
    Blay, Jean-Yves
    Le Cesne, Axel
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (11) : 957 - 963
  • [7] Real-world experience with pembrolizumab in patients with advanced soft tissue sarcoma
    Liu, Jiayong
    Bai, Chujie
    Li, Shu
    Xue, Ruifeng
    Gao, Tian
    Zhang, Lu
    Tan, Zhichao
    Fang, Zhiwei
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (04)
  • [8] Real-world investigation of the efficacy and safety of secukinumab for psoriasis treatment in a Chinese population
    Zeng, Jing-Xin
    Luo, Quan
    Wen, Ju
    Tian, Xin
    Zhou, Xin
    Li, Wei
    Tang, Ya-Ping
    Zhang, San-Quan
    Liu, Wei-Yu
    Zhu, Hui-Lan
    Zhang, Xi-Bao
    CHINESE MEDICAL JOURNAL, 2021, 134 (01) : 117 - 119
  • [9] Real-world investigation of the efficacy and safety of secukinumab for psoriasis treatment in a Chinese population
    Zeng Jing-Xin
    Luo Quan
    Wen Ju
    Tian Xin
    Zhou Xin
    Li Wei
    Tang Ya-Ping
    Zhang San-Quan
    Liu Wei-Yu
    Zhu Hui-Lan
    Zhang Xi-Bao
    中华医学杂志(英文版), 2021, 134 (01) : 117 - 119
  • [10] Interim results of a real-world observational study of eribulin in soft tissue sarcoma including rare subtypes
    Kobayashi, Eisuke
    Naito, Yoichi
    Asano, Naofumi
    Maejima, Aiko
    Endo, Makoto
    Takahashi, Shunji
    Megumi, Yasunori
    Kawai, Akira
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (10) : 938 - 946